178 institutions hold shares in GoodRx Holdings Inc. (GDRX), with 33.56M shares held by insiders accounting for 8.60% while institutional investors hold 96.92% of the company’s shares. The shares outstanding are 241.06M, and float is at 41.10M with Short Float at 24.58%. Institutions hold 88.59% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 3.45 million shares valued at $139.05 million. The investor’s holdings represent 7.85% of the GDRX Shares outstanding. As of Dec 30, 2020, the second largest holder is Silver Lake Group, LLC with 3.03 million shares valued at $122.24 million to account for 6.90% of the shares outstanding. The other top investors are Morgan Stanley which holds 2.7 million shares representing 6.16% and valued at over $109.11 million, while Goldman Sachs Group, Inc. holds 5.26% of the shares totaling 2.31 million with a market value of $93.24 million.
GoodRx Holdings Inc. (NASDAQ: GDRX) is 18.54% higher on its value in year-to-date trading and has touched a low of $33.51 and a high of $64.22 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GDRX stock was last observed hovering at around $49.64 in the last trading session, with the day’s loss setting it -1.82% off its average median price target of $51.00 for the next 12 months. It is also 31.69% off the consensus price target high of $70.00 offered by 15 analysts, but current levels are -64.9% lower than the price target low of $29.00 for the same period.
Currently trading at $47.82, the stock is -9.15% and 1.97% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.4 million and changing -3.67% at the moment leaves the stock 1.39% off its SMA200. The firm has a 50-day simple moving average (SMA 50) of $48.66 and a 200-day simple moving average (SMA200) of $47.17.
The stock witnessed a 7.51% In the last 1 month and extending the period to 3 months gives it a 25.84%, and is -14.47% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.27% over the week and 7.49% over the month.
GoodRx Holdings Inc. (GDRX) has around 413 employees, a market worth around $19.34B and $510.40M in sales. Fwd P/E is 139.42. Profit margin for the company is 3.90%. Distance from 52-week low is 42.70% and -25.54% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.30%).
GoodRx Holdings Inc. (GDRX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for GoodRx Holdings Inc. (GDRX) is a “Overweight”. 15 analysts offering their recommendations for the stock have an average rating of 2.30, where 6 rate it as a Hold and 0 think it is a “Overweight”. 8 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.
GoodRx Holdings Inc. is expected to release its quarterly report on 06/02/2021 and quarterly earnings per share for the current quarter are estimated at $0.06 with sales reaching $147.79M over the same period.The EPS is expected to grow by 50.80% this year.
GoodRx Holdings Inc. (GDRX) Insider Activity
A total of 11 insider transactions have happened at GoodRx Holdings Inc. (GDRX) in the last six months, with sales accounting for 4 and purchases happening 7 times.